SFI
AZN icon

Siemens Fonds Invest’s AstraZeneca AZN Stock Holding History

Siemens Fonds Invest’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,437
Closed -$713K – 581
2024
Q4 		$713K Buy
5,437
+520
+11% +$72.8K 0.05% 249
2024
Q3 		$347K Sell
4,917
-363
-7% -$58.6K 0.03% 332
2024
Q2 		$823K Hold
5,280
– – 0.06% 223
2024
Q1 		$715K Hold
5,280
– – 0.06% 239
2023
Q4 		$711K Buy
5,280
+1,230
+30% +$160K 0.06% 233
2023
Q3 		$549K Buy
+4,050
New +$553K 0.06% 239

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Siemens Fonds Invest's AZN Position: Q1 2025 in Review

Siemens Fonds Invest sold out of AstraZeneca (AZN) in Q1 2025, closing a stake of 5,437 shares — an estimated $713K sold.

Siemens Fonds Invest first reported a position in AZN in Q3 2023 and held it in 6 quarters. The position peaked at $823K in Q2 2024. 1,250 funds tracked by Wall St. Rank hold AZN as of Q1 2025.

  • Siemens Fonds Invest reported no remaining AstraZeneca position as of Q1 2025 after selling out during the quarter.
  • Siemens Fonds Invest sold 5,437 AstraZeneca shares in Q1 2025, an estimated $713K.
  • Siemens Fonds Invest first reported a position in AstraZeneca in Q3 2023 and held it in 6 quarters.
  • Siemens Fonds Invest's AstraZeneca position peaked at $823K in Q2 2024.
  • 1,250 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2025.

Based on Siemens Fonds Invest's 13F filing for Q1 2025, filed 15 May 2025.